BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37743336)

  • 21. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
    Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
    BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.
    Goetsch Weisman A; Weiss McQuaid S; Radtke HB; Stoll J; Brown B; Gomes A
    Am J Med Genet A; 2023 Oct; 191(10):2467-2481. PubMed ID: 37485904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization.
    Gugel I; Grimm F; Tatagiba M; Schuhmann MU; Zipfel J
    J Neurooncol; 2022 Sep; 159(2):271-279. PubMed ID: 35771312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
    Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
    Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?
    Murray AJ; Hughes TA; Neal JW; Howard E; Evans DG; Harper PS
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):269-71. PubMed ID: 16421138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
    Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
    Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
    Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
    HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New classification and approaches to the treatment of schwannomatosis.
    Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Diagnostic Dilemma: Multiple Primary Intracranial Tumors Without Vestibular Schwannomas.
    Faucett EA; Larsen BT; Khan R; Chiu AG; Chang EH
    Ann Otol Rhinol Laryngol; 2016 Nov; 125(11):938-942. PubMed ID: 27553596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant melanotic nerve sheath tumor of the posterior mediastinum].
    Buero A; Olivera Lopez SB; Tchercansky A; Pankl LG; Chimondeguy DJ; Samudio M; Mendez J; Lyons GA
    Medicina (B Aires); 2024; 84(2):324-328. PubMed ID: 38683517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
    Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
    Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas.
    Peyre M; Gaudric J; Bernat I; André A; Couture T; Kalamarides M
    Neurosurg Rev; 2023 Oct; 46(1):275. PubMed ID: 37857782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What to know about schwannomatosis: a literature review.
    Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
    Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
    Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
    J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Familial schwannomatosis, a new entity distinct from neurofibromatosis type 1 and 2].
    Reinders JW; Koehler PJ
    Ned Tijdschr Geneeskd; 2007 Aug; 151(34):1891-5. PubMed ID: 17902564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors.
    Strowd RE
    Curr Treat Options Oncol; 2020 Aug; 21(10):81. PubMed ID: 32767156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
    Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
    Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
    Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
    Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.